Evidence map›Paper›PMID 38026503›Full record

ArticleTobacco induced diseases2023

Tobacco endgame in the WHO European Region: Feasibility in light of current tobacco control status.

Adrián González-Marrón, Helena Koprivnikar, Judit Tisza, Zsuzsa Cselkó, Angeliki Lambrou, Armando Peruga, Biljana Kilibarda, Cristina Lidón-Moyano, Dolors Carnicer-Pont, Efstathios Papachristou and 15 more

Open access · goldAbstract read
In one paragraph

Article in Tobacco induced diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 15 institutions in 14 countries.

Adrián González-MarrónGroup of Evaluation of Health Determinants and Health Policies, Department of Basic Sciences, Universitat Internacional de Catalunya, Sant Cugat del Vallès, Spain.
Helena KoprivnikarNational Institute of Public Health, Slovenia.
Judit TiszaNational Korányi Institute of Pulmonology, Budapest, Hungary.
Zsuzsa CselkóNational Korányi Institute of Pulmonology, Budapest, Hungary.
Angeliki LambrouDirectorate of Epidemiology and Prevention of Non-Communicable Diseases and Injuries, National Public Health Organization (NPHO), Athens, Greece.
Armando PerugaGrupo de Investigación en Control del Tabaco, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, España.
Biljana KilibardaInstitute of Public Health of Serbia "Dr Milan Jovanovic Batut", Belgrade, Serbia.
Cristina Lidón-MoyanoGroup of Evaluation of Health Determinants and Health Policies, Department of Basic Sciences, Universitat Internacional de Catalunya, Sant Cugat del Vallès, Spain.
Dolors Carnicer-PontGrupo de Investigación en Control del Tabaco, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, España.
Efstathios PapachristouDirectorate of Epidemiology and Prevention of Non-Communicable Diseases and Injuries, National Public Health Organization (NPHO), Athens, Greece.
Emilia NunesGeneral Directorate of Health, Ministry of Health, Lisbon, Portugal.
Giulia CarrerasClinical Epidemiology Unit, Oncologic network, prevention and research institute (ISPRO), Florence, Italy.
Giuseppe GoriniClinical Epidemiology Unit, Oncologic network, prevention and research institute (ISPRO), Florence, Italy.
Hipólito Pérez-MartínGroup of Evaluation of Health Determinants and Health Policies, Department of Basic Sciences, Universitat Internacional de Catalunya, Sant Cugat del Vallès, Spain.
Jose M Martínez-SánchezGroup of Evaluation of Health Determinants and Health Policies, Department of Basic Sciences, Universitat Internacional de Catalunya, Sant Cugat del Vallès, Spain.
Lorenzo SpizzichinoMinistry of Health, Rome, Italy.
Maria KareklaUniversity of Cyprus, Nicosia, Cyprus.
Maurice MulcahyNational Environmental Health Service, Health Service Executive (HSE), Galway Business Park, Dangan, Ireland.
Milena VasicInstitute of Public Health of Serbia "Dr Milan Jovanovic Batut", Belgrade, Serbia.
Otto RuokolainenFinnish Institute for Health and Welfare, Helsinki, Finland.
Romain GuignardSanté Publique France, the French National Public Health Agency, Saint-Maurice, France.
Sotiria SchoretsanitiDirectorate of Epidemiology and Prevention of Non-Communicable Diseases and Injuries, National Public Health Organization (NPHO), Athens, Greece.
Tiina LaatikainenFinnish Institute for Health and Welfare, Helsinki, Finland.
Viêt Nguyen-ThanhSanté Publique France, the French National Public Health Agency, Saint-Maurice, France.
Hanna OllilaFinnish Institute for Health and Welfare, Helsinki, Finland.
Universitat Internacional de Catalunya · ESNational Public Health Organization · GRFinnish Institute for Health and Welfare · FIInstitute of Public Health of Serbia · RSOrszágos Korányi Tbc és Pulmonológiai Intézet · HUPrevention Institute · USSanté Publique France · FRHealth Service Executive · IEInstitut d'Investigació Biomédica de Bellvitge · ESMinistero della Salute · ITMinistry of Health · PTNational Institute of Public Health · SIUniversidad del Desarrollo · CLUniversity of Cyprus · CYUniversity of Eastern Finland · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTo assess the feasibility of developing World Health Organization (WHO) European Region countries' goals and measures in line with tobacco endgame objectives, information on the current tobacco control context and capacity is needed. The aim of this study was to assess the implementation of the Framework Convention on Tobacco Control (WHO FCTC) and MPOWER measures in the region.

methodsIn this cross-sectional study we used data from the WHO FCTC implementation reports and MPOWER from 2020 in 53 WHO European Region countries. Six domains (i.e. capacity, taxation and price policies, other national key regulations, public awareness raising and communication, tobacco use cessation, and monitoring) were formed. Subsequently, available indicators under these domains were scored and the level of implementation was computed for each country. Mann-Whitney tests were carried out to compare the scores between the group of countries with and without official endgame goals.

resultsOverall, implementation of the WHO FCTC with the selected indicators at the country level ranged from 28% to 86%, and of MPOWER from 31% to 96%. Full implementation was achieved by 28% of WHO FCTC Parties in the region in taxation and price policies, 12% in public awareness raising and communication, and 42% in monitoring. In capacity, tobacco use cessation and other national key regulations, none of the Parties in the region reached full implementation. Overall median WHO FCTC scores were significantly higher in countries with official endgame goals than in those without (p<0.001).

conclusionsThere is unequal implementation of both WHO FCTC and MPOWER measures among WHO European Region countries. MPOWER and WHO FCTC provide all the measures for the necessary first steps, followed by innovative measures, to accomplish tobacco endgame goals.

Indexed as

advertising and promotioncessationend gamepackaging and labellingpublic policy

Identifiers

PMID38026503
PMCPMC10647070
OpenAlexW4388699495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.